Farmalys
ActiveFarmalys is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show equity of €17k and a net result of €15k. Its solvency ranks better than 41% of 16426 sector peers (fiscal year 2025). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
84
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Every signal that weighs is under Signals.
Axes
Profitability100
Solvency77
Growth-
Track record50
Credit verdict
Credit up to €1k at 30 days acceptable
Liquidity ample (current ratio 2.09; short-term debt: 47.9% and cash: 68% of total assets), and 47.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
Founded in 2025, under 3 years, statistically higher risk.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-08-2026, 23 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filingDeviation from the deadline
2025
23 d late
← before the deadline
after the deadline →
Financials · fiscal year 2025, micro schema
Equity
€17k
Total assets
€34k
Net result
€15k
Working capital
€17k
Turnover and EBIT margin not published: the micro schema does not require them.
Balance-sheet composition
Equity and liabilities €34k
Equity
€17k
Debt
€16k
Debt finances 47.9% of the balance-sheet total.
Key figures and ratios
Solvency
52.1%
Current ratio
2.09
Quick ratio
2.09
Debt / equity
0.92
ROE
87.6%
ROA
45.6%
Debt
€16k
Debt ≤ 1 year
€16k
Income taxes
€6k
Filed annual accounts
As filed with the NBB · 2025
Balance sheet
Code2025
Assets
Total assets20/58€34k
Current assets29/58€34k
Amounts receivable within one year40/41€11k
Trade receivables40€11k
Cash at bank and in hand54/58€23k
Equity and liabilities
Total equity and liabilities10/49€34k
Equity10/15€17k
Contributions10/11€3k
Profit (loss) carried forward14€14k
Amounts payable17/49€16k
Amounts payable within one year42/48€16k
Financial debts43€480
Credit institutions430/8€480
Trade debts44€2k
Suppliers440/4€2k
Taxes, remuneration and social security45€12k
Taxes450/3€12k
Other amounts payable47/48€2k
Income statement
Code2025
Other operating charges640/8€486
Gross operating margin9900€21k
Operating profit (loss)9901€21k
Profit (loss) for the period before taxes9903€21k
Income taxes67/77€6k
Profit (loss) for the period9904€15k
Profit (loss) for the period to be appropriated9905€15k
Appropriation of the result
Profit (loss) to be appropriated9906€15k
Profit to be distributed694/7€833
Return on contributions (dividend)694€833
The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
23-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 23 days late
NBB filing
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2025
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Andrée Dumontgaarde 21180 UkkelGround area
3,016 m²
Building footprint
576 m²
Volume, LiDAR
97 m³
Parcel 21614F0453/00L005, Brussels · tallest building 2.9 m. Linked by address, not a title deed.
1 establishment unit
Farmalys
since 20252.380.426.421
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21614F0453/00L005 | Brussels | 3,016 m² | 1 · 576 m² | 2.9 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
EKivitae
BE 0794.228.872
Fleurus · Eq €16k
Delsipée Véronique
BE 1029.427.148
Jurbise · Eq €19k
Personal Coach 4U
BE 1022.349.316
Wommelgem · Eq €15k
Radical Health Co
BE 0725.921.274
Herentals · Eq €14k
DR. MILAN SCHREUER & CO
BE 0794.126.033
Sint-Joost-ten-Node · Eq €24k
Of 1,005 companies in sector 86999 we hold annual accounts for 34. 22 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-10-2025
Fiscal year end31-12
Activities, NACEBEL
86999Other human health activities
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
47730Retail sale of pharmaceutical products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers
Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.